Related references
Note: Only part of the references are listed.Non-viral precision T cell receptor replacement for personalized cell therapy
Susan P. P. Foy et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun et al.
NATURE (2023)
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma
Samuel Coleman et al.
MOLECULAR CARCINOGENESIS (2023)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities
Maisoon Matareed et al.
JOURNAL OF PATHOLOGY (2023)
Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas
Mona Meng Wang et al.
FRONTIERS IN IMMUNOLOGY (2023)
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Jie Yin et al.
PHARMACEUTICALS (2023)
Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis
James Draper et al.
CURRENT EYE RESEARCH (2023)
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Zaoqu Liu et al.
NATURE COMMUNICATIONS (2022)
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling
John J. Park et al.
CANCER GENE THERAPY (2022)
Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review
Szonja Anna Kovacs et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Soumya Badrinath et al.
NATURE (2022)
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Brandie C. Taylor et al.
FRONTIERS IN IMMUNOLOGY (2022)
Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer
Zengqing Guo et al.
NPJ PRECISION ONCOLOGY (2022)
Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
Chunmei Fu et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
Silvia D'Amico et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
Lina S. Farhoumand et al.
CANCERS (2022)
Tebentafusp for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma
Lanyi Nora Chen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2022)
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
Richard D. Carvajal et al.
NATURE MEDICINE (2022)
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
Shaheer Khan et al.
FRONTIERS IN ONCOLOGY (2022)
Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
Mona Meng Wang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Tebentafusp for uveal melanoma
David Killock
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?
Chiara L. Blomen et al.
CANCERS (2021)
Five-year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma
Hisashi Uhara et al.
JOURNAL OF DERMATOLOGY (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
Enhancing programmed cell death protein 1 axis inhibition in head and neck squamous cell carcinoma: Combination immunotherapy
Ioannis A. Vathiotis et al.
CANCER TREATMENT REVIEWS (2021)
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu et al.
CLINICAL CANCER RESEARCH (2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The association between CD8+tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
Feng Li et al.
ECLINICALMEDICINE (2021)
The future of microfluidics in immune checkpoint blockade
Jonathan Briones et al.
CANCER GENE THERAPY (2021)
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
Kirsty Ford et al.
CANCER RESEARCH (2020)
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
Carlos R. Figueiredo et al.
JOURNAL OF PATHOLOGY (2020)
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors
Agata Mlynska et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region
Sarah E. Coupland et al.
JAMA OPHTHALMOLOGY (2020)
Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells
Fabricio C. Machado et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma
Sophie Thornton et al.
CANCERS (2020)
New tools to prevent cancer growth and spread: a 'Clever' approach
Maija Hollmen et al.
BRITISH JOURNAL OF CANCER (2020)
Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture
Karen Aughton et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh et al.
LIFE SCIENCES (2020)
T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
Christopher J. Hanley et al.
BRITISH JOURNAL OF CANCER (2020)
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou et al.
MOLECULAR CANCER (2020)
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
Vincent Chau et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections
Hongrun Zhang et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
MIF-Dependent Control of Tumor Immunity
Jordan T. Noe et al.
FRONTIERS IN IMMUNOLOGY (2020)
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
Ricardo A. de Azevedo et al.
ONCOIMMUNOLOGY (2020)
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
Nicola Principe et al.
FRONTIERS IN IMMUNOLOGY (2020)
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour et al.
ONCOIMMUNOLOGY (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Trial watch: STING agonists in cancer therapy
Julie Le Naour et al.
ONCOIMMUNOLOGY (2020)
Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy
Sara Valpione et al.
NATURE CANCER (2020)
Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors
Miro Viitala et al.
CLINICAL CANCER RESEARCH (2019)
Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis
Wei Jian Tan et al.
BLOOD (2019)
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
Paola Queirolo et al.
SEMINARS IN CANCER BIOLOGY (2019)
Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes
Pierre L. Triozzi et al.
ONCOIMMUNOLOGY (2019)
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
Jonathan A. Trujillo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
Jason J. Luke et al.
CLINICAL CANCER RESEARCH (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
Elise Ramia et al.
ONCOIMMUNOLOGY (2019)
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng et al.
CANCER DISCOVERY (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
Guang-Tao Yu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity
Logan K. Smith et al.
IMMUNITY (2018)
TGF-β Inhibition and Immunotherapy: Checkmate
Karuna Ganesh et al.
IMMUNITY (2018)
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Scott J. Rodig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF beta enhance the efficacy of cancer immunotherapy
Rajani Ravi et al.
NATURE COMMUNICATIONS (2018)
Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
Carlos R. Figueiredo et al.
FRONTIERS IN IMMUNOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A. Trujillo et al.
CANCER IMMUNOLOGY RESEARCH (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level RORγt Expression
Bofeng Li et al.
JOURNAL OF IMMUNOLOGY (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Dmitrij Ostroumov et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C. Hopkins et al.
JCI INSIGHT (2018)
Adipophilin expression in primary and metastatic uveal melanoma: a pilot study
Miltiadis Fiorentzis et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
Smita S. Chandran et al.
LANCET ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells
Xing Guo et al.
ONCOTARGET (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
PKCβ : Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol
Devina Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Gerty Schreibelt et al.
CLINICAL CANCER RESEARCH (2016)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
Yosuke Ohno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
TCR Signal Strength Alters T-DC Activation and Interaction Times and Directs the Outcome of Differentiation
Nicholas van Panhuys
FRONTIERS IN IMMUNOLOGY (2016)
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
Jianda Yuan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo
Carlos R. Figueiredo et al.
SCIENTIFIC REPORTS (2015)
Two Distinct Uveal Melanomas in the Same Eye
Ebba J. Nissen et al.
JAMA OPHTHALMOLOGY (2015)
Use of the Chick Embryo Model in Uveal Melanoma
Helen Kalirai et al.
OCULAR ONCOLOGY AND PATHOLOGY (2015)
Uveal Melanoma Patient-Derived Xenografts
Guillaume Carita et al.
OCULAR ONCOLOGY AND PATHOLOGY (2015)
Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
H. Kalirai et al.
BRITISH JOURNAL OF CANCER (2014)
Clever-1/Stabilin-1 Controls Cancer Growth and Metastasis
Marika Karikoski et al.
CLINICAL CANCER RESEARCH (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells
Shasha Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation
Bryan Vander Lugt et al.
NATURE IMMUNOLOGY (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S. Wilgenhof et al.
ANNALS OF ONCOLOGY (2013)
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
Jurjen Tel et al.
CANCER RESEARCH (2013)
Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10
Karen Bobadilla et al.
IMMUNOLOGY (2013)
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
An M. T. Van Nuffel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment
David Simons et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-γ-induced MHC class II molecule on primary human blood macrophages
Lally L. Y. Chan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The MIF Homologue D-Dopachrome Tautomerase Promotes COX-2 Expression through β-Catenin-Dependent and -Independent Mechanisms
Dan Xin et al.
MOLECULAR CANCER RESEARCH (2010)
Lipid accumulation and dendritic cell dysfunction in cancer
Donna L. Herber et al.
NATURE MEDICINE (2010)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
M. Campoli et al.
ONCOGENE (2008)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
MIF signal transduction initiated by binding to CD74
L Leng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
